Hycor's arthritis test gets FDA clearance:
This article was originally published in Clinica
Hycor Biomedical has received 510(k) FDA clearance to market its Rheumatoid Factor (RF) IgA ELISA autoimmune test. The test completes a series of rheumatoid arthritis tests from Hycor and complements the RF IgM and RF IgG tests previously cleared for marketing by the FDA. All tests can be performed using a manual procedure as well as in a fully automated mode on Hycor's new HYoTEC 288 automated immunoassay system, the Garden Grove, California-based company said.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.